Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Appropriations

    Back to Income Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹7,955 Cr₹9,508 Cr₹8,175 Cr₹7,300 Cr₹6,391 Cr

What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?

The latest Appropriations ratio of GLENMARK PHARMACEUTICALS is ₹7,955 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹7,955 Cr
Mar2024₹9,508 Cr
Mar2023₹8,175 Cr
Mar2022₹7,300 Cr
Mar2021₹6,391 Cr

How is Appropriations of GLENMARK PHARMACEUTICALS Trending?

Years Appropriations % Change
Mar2025 ₹7,955 Cr
-16.33
Mar2024 ₹9,508 Cr
16.30
Mar2023 ₹8,175 Cr
12.00
Mar2022 ₹7,300 Cr
14.22
Mar2021 ₹6,391 Cr -

Compare Appropriations of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,818.9 Cr 3.2% 4.6% 50.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.2%

4.6%

50.6%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses